Acquisition synergies SIGMA has become part of the ZETA Group as of 2025, presenting a direct channel for cross-sell of ZETA’s broader pharmaceutical and biotech automation capabilities alongside SIGMA’s process and manufacturing intelligence offerings.

Pharma/biotech focus Established relationships with pharma, biotech, vaccine development, diagnostics, and related sectors offer a ready-made entry point for expanded automation, process optimization, and compliance-driven projects.

End-to-end automation Core expertise spans process automation, instrumentation, and manufacturing intelligence, enabling a persuasive value proposition for projects requiring integrated solutions from planning through optimization.

Sustainability drive Positioned messaging emphasizes efficiency, safety, and sustainability, aligning with customer mandates for lower operating risk, better asset utilization, and greener processing in regulated industries.

Regional footprint Based in Bavaria with 51-200 employees and a strong technical stack, SIGMA can leverage regional presence to pursue pilot implementations, reference sites, and scalable regional deployments.